Biotech con piattaforma di delivery nano-in-micro a base di nanoparticelle di fosfato di calcio per lo scompenso cardiaco.
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Series A NanoPhoria closed an €83.5 million Series A led by XGEN Venture, Sofinnova Partners and CDP Venture Capital, the largest Italian biotech Series A. | $96.9M |